Berglund J, Christensen S B, Hallengren B
Department of Surgery University of Lund, Malmö General Hospital, Sweden.
J Intern Med. 1990 Feb;227(2):137-41. doi: 10.1111/j.1365-2796.1990.tb00132.x.
During a 5-year period, 333 new cases of thyrotoxicosis were diagnosed in a well-defined urban population of 258,000 inhabitants in southern Sweden without a history of endemic goitre. This corresponds to a mean annual incidence of thyrotoxicosis of 25.8/100,000. The incidence of Graves' disease was 17.7, the incidence of toxic nodular goitre was 5.4 and that of solitary toxic adenoma was 2.7/100,000/year. The peak age-specific incidence of Graves' disease was 32.6/100,000/year (age group 60-69 years), and that of toxic nodular goitre and solitary toxic adenoma was 31.5/100,000/year (age group over 80 years).
在5年期间，瑞典南部一个明确界定的拥有25.8万居民且无地方性甲状腺肿病史的城市人口中，诊断出333例新的甲状腺毒症病例。这相当于甲状腺毒症的年平均发病率为25.8/10万。格雷夫斯病的发病率为17.7/10万，毒性结节性甲状腺肿的发病率为5.4/10万，孤立性毒性腺瘤的发病率为2.7/10万/年。格雷夫斯病的年龄特异性发病率峰值为32.6/10万/年（60 - 69岁年龄组），毒性结节性甲状腺肿和孤立性毒性腺瘤的年龄特异性发病率峰值为31.5/10万/年（80岁以上年龄组）。
